Ken Powell is the President of Genesis Business Development, a health care consultancy. Mr. Powell has experience in the identification, acquisition, and commercialization of new businesses and products in the clinical diagnostics, life sciences and medical device market segments. He has provided international Expert Witness Testimony. Mr. Powell is knowledgeable about emerging technologies, M&A, personalized medicine, molecular diagnostics, "next-gen" sequencing, hospital, commercial reference, physician lab and OTC segments, clinical lab systems, point-of-care, genomics, life sciences, distributors and medical devices. Mr. Powell is also knowledgeable about evolving regulatory and reimbursement issues. He has held senior management positions with Becton Dickinson, Roche Diagnostics, Technicon, Armour Pharmaceuticals, and Upjohn Clinical Laboratory Procedures. Mr. Powell is conversant in all aspects of clinical diagnostics, life sciences segments, public and private companies.